1. Home
  2. ASBP vs SURG Comparison

ASBP vs SURG Comparison

Compare ASBP & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASBP
  • SURG
  • Stock Information
  • Founded
  • ASBP 2021
  • SURG 2006
  • Country
  • ASBP United States
  • SURG United States
  • Employees
  • ASBP N/A
  • SURG N/A
  • Industry
  • ASBP Biotechnology: Pharmaceutical Preparations
  • SURG Advertising
  • Sector
  • ASBP Health Care
  • SURG Consumer Discretionary
  • Exchange
  • ASBP Nasdaq
  • SURG Nasdaq
  • Market Cap
  • ASBP 26.6M
  • SURG 27.0M
  • IPO Year
  • ASBP N/A
  • SURG N/A
  • Fundamental
  • Price
  • ASBP $0.57
  • SURG $2.49
  • Analyst Decision
  • ASBP
  • SURG Strong Buy
  • Analyst Count
  • ASBP 0
  • SURG 1
  • Target Price
  • ASBP N/A
  • SURG $8.50
  • AVG Volume (30 Days)
  • ASBP 216.1K
  • SURG 4.8M
  • Earning Date
  • ASBP 05-24-2025
  • SURG 05-12-2025
  • Dividend Yield
  • ASBP N/A
  • SURG N/A
  • EPS Growth
  • ASBP N/A
  • SURG N/A
  • EPS
  • ASBP N/A
  • SURG N/A
  • Revenue
  • ASBP N/A
  • SURG $60,881,173.00
  • Revenue This Year
  • ASBP N/A
  • SURG $59.57
  • Revenue Next Year
  • ASBP N/A
  • SURG $75.47
  • P/E Ratio
  • ASBP N/A
  • SURG N/A
  • Revenue Growth
  • ASBP N/A
  • SURG N/A
  • 52 Week Low
  • ASBP $0.40
  • SURG $1.05
  • 52 Week High
  • ASBP $15.80
  • SURG $4.38
  • Technical
  • Relative Strength Index (RSI)
  • ASBP N/A
  • SURG 66.39
  • Support Level
  • ASBP N/A
  • SURG $2.18
  • Resistance Level
  • ASBP N/A
  • SURG $2.52
  • Average True Range (ATR)
  • ASBP 0.00
  • SURG 0.30
  • MACD
  • ASBP 0.00
  • SURG 0.00
  • Stochastic Oscillator
  • ASBP 0.00
  • SURG 83.12

About ASBP Aspire Biopharma Holdings Inc. Common Stock

Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tract.

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; Lead Generation is a generation and case management solutions company serving law firms in the mass tort industry; and Others. It generates the revenue from Mobile Virtual Network Operator segment.

Share on Social Networks: